Medical Design Briefs - January 2025 - 20

Design Briefs
The Vital Role of TPE Tubing in Scalability and
Rapid Deployment
By Anthony Christopher, Kent Elastomer Products
n the rapidly evolving landscape of biopharmaceuticals,
adaptability and responsiveness
are key to staying competitive
and delivering life-saving therapies to
patients worldwide. This article explores
the critical role that thermoplastic elastomer
(TPE) biopharmaceutical tubing
plays in enabling scalability and rapid
deployment - a duo of factors that can
make all the difference in the industry.
Scaling Up with Ease
The biopharmaceutical industry often
faces the challenge of scaling up production
to meet increasing demand for therapies.
Traditional manufacturing processes
involving rigid stainless-steel
equipment can be cumbersome and
time-consuming to scale. This is where
TPE tubing comes into play. TPE is flexible,
modular, and versatile.
Benefits
range from shorter lead times to reduced
validation times.
Flexible and Modular. TPE tubing's
inherent flexibility allows for quick and
easy integration into different equipment
configurations. This adaptability
reduces the need for extensive customiI
zation,
minimizing setup time, and accelerating
the scaling process. TPE tubing
systems are also designed with
modularity in mind. This means that as a
manufacturer's production needs grow,
tubing components can simply be added
or changed without a major overhaul of
an entire system. It's like building with
building blocks, ensuring a smooth and
efficient scaling process.
Versatile Applications. TPE tubing is
suitable for rapid Installation. It is lightweight
and easy to handle, simplifying
installation and setup. This translates
into reduced downtime and faster rampup
during the scaling process. It can be
used in various bioprocessing applications,
including filtration, chromatography,
and fluid transfer. Its versatility allows
biopharmaceutical manufacturers
to scale their operations across different
stages of the production process.
Speed to Market
In the competitive biopharmaceutical
landscape, time is crucial. Rapid deployment
of manufacturing processes is
a critical factor in getting life-saving
therapies to patients in a timely manner.
Shortened lead times, reduced validation
time, and an agile response must
be considered.
Shortened Lead Times. TPE tubing's
off-the-shelf availability means that manufacturers
can quickly acquire the necessary
components without long lead
times. This agility is especially crucial
when responding to urgent demands or
shifting market dynamics.
Reduced Validation Time. Single-use
TPE tubing systems often require less validation
compared to traditional stainless-steel
systems. This means that manufacturers
can get production up and running
faster, reducing the time it takes to bring
new therapies to market.
Agile Response. The biopharmaceutical
industry is marked by ever-changing requirements
and unforeseen challenges.
TPE tubing allows manufacturers to respond
quickly to these changes, whether
it's adapting to new processes or addressing
unexpected production needs.
Conclusion
Scalability and rapid deployment are
not mere buzzwords in the biopharmaceutical
industry; they are critical components
of success. TPE biopharmaceutical
tubing empowers manufacturers with
the flexibility, modularity, versatility, and
speed necessary to meet the challenges
of a fast-paced and evolving industry.
By recognizing and harnessing the potential
of TPE tubing, biopharmaceutical
companies can optimize their production
processes, reduce time to
market, and ultimately deliver life-saving
therapies more efficiently. In an industry
where every moment counts, the importance
of scalability and rapid deployment
cannot be overstated, and TPE tubing
stands at the forefront of this
transformative approach to biopharmaceutical
manufacturing.
This article was written by Anthony
TPE tubing's inherent flexibility allows for quick and easy integration into different equipment configurations. (Credit:
Kent Elastomer Products)
20
www.medicaldesignbriefs.com
Christopher, Commercial Manager of
Bioprocessing, Kent Elastomer Products,
Kent, OH. For more information,
visit www.kentelastomer.com.
Medical Design Briefs, January 2025

http://www.kentelastomer.com http://www.medicaldesignbriefs.com

Medical Design Briefs - January 2025

Table of Contents for the Digital Edition of Medical Design Briefs - January 2025